ARCHIVES

Part One Of A Two-Part Interview With NCI Director Harold Varmus

This article is from The Cancer Letter archive.

Vol. 37 No. 29 | July 22, 2011

Download PDF Visit The Full Archive

Related Articles

Herceptin With Adjuvant Chemo Improves Disease-Free Survival, Phase III Trial Finds

January 29, 2010

Cancer Vaccine RFAs Approved In Concept By NCI Advisors

July 26, 1991

DCT Programs Status Reported to Board

July 5, 1985

DCT’s Experimental Therapeutic Program Outlined to Board

May 2, 1975

In Brief: $100 Million Being Spent On Interferon In U.S., Rauscher Says; DeVita; Criticism Deserved

April 4, 1980

Constance Percy Retires From NCI After 30 Years.

November 10, 2000